Aggregator
Daily briefing: What’s next for Syria’s science? A view from <i>Nature</i>’s reporter who was a refugee
Why the genetic-testing revolution left some people behind — and what to do about it
What should we do if AI becomes conscious? These scientists say it’s time for a plan
Engineered cells take drugs deep into the brain ― and nowhere else
IL-23R is a senescence-linked circulating and tissue biomarker of aging
Challenges for aging research in Lebanon in times of crisis and conflict
Satellites are no silver bullet for methane monitoring
How CRISPR patent issues block Indian farmers from accessing biotech benefits
Ancient DNA data hold insights into past organisms and ecosystems — handle them with more care
AI decodes the calls of the wild
Claims that dam removals were to blame for Valencia floods are false
Stop digital platforms treating people as lab rats
Is the telescope pointing the right way?
Use existing foundations to build up citizen science for the SDGs
Large language models can help to translate science into real-world impact
Governments are banning kids from social media: will that protect them from harm?
A featherweight baby planet is fading away with age
‘Extraordinary’ globetrotting humpback whale tracked down with tail-recognition software
Happywhale software shows animal crossed oceans, traveled more than 13,000 kilometers
Judge blocks rule that eased U.S. reviews of biotech crops
Some plant researchers fear the setback could last years and will stifle innovation
Beyond the blur: Scopolamine's utility and limits in modeling cognitive disorders across sexes - Narrative review
Scopolamine, widely regarded as the gold standard in preclinical studies of memory impairments, acts as a non-selective antagonist of central and peripheral muscarinic receptors. While its application in modeling dementia primarily involves antagonism at the M(1) receptor, its non-selective peripheral actions may introduce adverse effects that influence behavioral test outcomes. This review analyzes preclinical findings to consolidate knowledge on scopolamine's use and elucidate potential...